INTERGRATED DIA.H DL 025 Total Assets
INTERGRATED DIA.H DL 025 total assets. Based on the latest financial reports, INTERGRATED DIA.H DL 025 (8I8) holds total assets worth €6.77 Billion EUR (≈ $7.91 Billion USD) as of June 2024. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see INTERGRATED DIA.H DL 025 market capitalisation for the company's overall valuation and market capitalisation.
Total Assets of INTERGRATED DIA.H DL 025 (2021–2025)
Total assets of INTERGRATED DIA.H DL 025 from 2021 to 2025. This chart illustrates how INTERGRATED DIA.H DL 025's total assets have evolved over time, based on quarterly financial data. See INTERGRATED DIA.H DL 025 stock quote for real-time trading data and today's change.
INTERGRATED DIA.H DL 025 - Asset Composition Analysis
INTERGRATED DIA.H DL 025 Total Assets Breakdown (December 2025)
INTERGRATED DIA.H DL 025 total assets breakdown as of December 2025. INTERGRATED DIA.H DL 025's total assets of €6.77 Billion consist of 46.0% current assets and 54.0% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 19.4% |
| Accounts Receivable | €996.49 Million | 11.6% |
| Inventory | €424.43 Million | 4.9% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €515.82 Million | 6.0% |
| Goodwill | €1.34 Billion | 15.6% |
Asset Composition Trend (2021–2025)
This chart illustrates how INTERGRATED DIA.H DL 025's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore INTERGRATED DIA.H DL 025 short-term liquidity ratio to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: INTERGRATED DIA.H DL 025's current assets represent 46.0% of total assets in 2025, a decrease from 48.8% in 2021.
- Cash Position: Cash and equivalents constituted 19.4% of total assets in 2025, up from 14.3% in 2021.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 21.0% of total assets, a decrease from 26.0% in 2021.
- Asset Diversification: The largest asset category is goodwill at 15.6% of total assets.
INTERGRATED DIA.H DL 025 Competitors by Total Assets
Key competitors of INTERGRATED DIA.H DL 025 based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Revvity Inc.
NYSE:RVTY
|
USA | $12.00 Billion |
|
Guangzhou Kingmed Diagnostics Group Co Ltd
SHG:603882
|
China | CN¥9.20 Billion |
|
Vijaya Diagnostic Centre Limited
NSE:VIJAYA
|
India | Rs15.07 Billion |
|
ALPHAHELIX MOL.DIAGN. SK1
F:4MB
|
Germany | €18.96 Million |
|
Sonic Healthcare Ltd
AU:SHL
|
Australia | AU$16.78 Billion |
|
Integral Diagnostics Ltd
AU:IDX
|
Australia | AU$1.43 Billion |
|
Australian Clinical Labs Ltd
AU:ACL
|
Australia | AU$562.50 Million |
|
Healius Ltd
AU:HLS
|
Australia | AU$1.77 Billion |
INTERGRATED DIA.H DL 025 - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.59 | - | - |
| Quick Ratio | 1.32 | - | - |
| Cash Ratio | 0.00 | - | - |
| Working Capital | €1.01 Billion | - | - |
INTERGRATED DIA.H DL 025 - Advanced Valuation Insights
This section examines the relationship between INTERGRATED DIA.H DL 025's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 5.27 |
| Latest Market Cap to Assets Ratio | 0.03 |
| Asset Growth Rate (YoY) | 20.6% |
| Total Assets | €8.60 Billion |
| Market Capitalization | $251.46 Million USD |
Valuation Analysis
Below Book Valuation: The market values INTERGRATED DIA.H DL 025's assets below their book value (0.03x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: INTERGRATED DIA.H DL 025's assets grew by 20.6% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for INTERGRATED DIA.H DL 025 (2021–2025)
The table below shows the annual total assets of INTERGRATED DIA.H DL 025 from 2021 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | €8.60 Billion ≈ $10.05 Billion |
+20.56% |
| 2024-12-31 | €7.13 Billion ≈ $8.33 Billion |
+23.55% |
| 2023-12-31 | €5.77 Billion ≈ $6.75 Billion |
+8.95% |
| 2022-12-31 | €5.30 Billion ≈ $6.19 Billion |
-15.07% |
| 2021-12-31 | €6.24 Billion ≈ $7.29 Billion |
-- |
About INTERGRATED DIA.H DL 025
Integrated Diagnostics Holdings plc operates as a consumer healthcare company that provides medical diagnostics services to patients. It offers approximately 3,000 diagnostic pathology tests, such as immunology, microbiology, haematology, endocrinology, clinical chemistry, molecular biology, parasitology, histopathology, and genetics. The company also provides radiology services, such as positron… Read more